Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2002

View Archived Issues

Antalarmin, a CRF1 antagonist, for the therapy of anxiety

SN-38 induces cell cycle arrest and apoptosis in human testicular cancer cells

Structure of FAAH elucidated

Arzoxifene and LG-100268 effective alone and in combination in a rat breast cancer model

Shigella vaccine is safe and immunogenic in phase I trial

Alliance and Mixture Sciences enter technology license agreement

Statistically significant preliminary results in Visudyne study in minimally classic wet AMD

Fujisawa expands topical Atrisone collaboration with Atrix

VaxGen and Kaketsuken sign agreement for smallpox vaccine development

Efficacy of alicaforsen reported in patients with active Crohn's disease

Antiarrhythmic action of a novel arylpiperazine RSD-992 shown in rats and guinea pigs

CP-461 well tolerated in a phase I trial in patients with advanced cancer

Phase II asthma trial of interferon gamma-1b completes randomization

Initial milestone achieved in Applied Molecular Evolution/Chiron collaboration

AVI BioPharma and International Therapeutics to develop NeuGene compounds for HIV

Drug pipeline for allergic rhinitis

BLA amendment for Xolair includes new data

Phase II trial of VX-148 in psoriasis patients commences in Iceland

Novel inhibitors of cytokine production covered by Boehringer Ingelheim patent

Aventis researchers design novel agents for in vitro and in vivo nucleic acid delivery

Decalactones of fungal origin reported to exhibit antitumor and antiinfective activity

New antithrombotic 5-thio-beta-D-xylopyranose derivatives under study at Fournier

Piperidine-based motilin agonists described by Solvay

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...